2025年7月3日,总部位于北京的尚高生命科学(一家在特拉华州注册的企业)宣布,其多数有表决权股东已通过一项反向股票拆分决议。公司董事会由首席执行官Jennifer Zhan领导,正式确认这一决策。后续,有关反向拆分的具体细节将及时向股东传达。
2025年7月3日,总部位于北京的尚高生命科学(一家在特拉华州注册的企业)宣布,其多数有表决权股东已通过一项反向股票拆分决议。公司董事会由首席执行官Jennifer Zhan领导,正式确认这一决策。后续,有关反向拆分的具体细节将及时向股东传达。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.